Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Toboni

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
Menopause (New York, N.Y.)|January 13, 2016
Contributing factors for menopausal symptoms after surgical staging for endometrial cancerKoji Matsuo, Marc R Gualtieri, Sigita S Cahoon, et al.
Gynecologic Oncology|January 21, 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcomaMichael D Toboni, Kaitlyn Dinkins, Sharon Wu, et al.
Gynecologic Oncology|August 2, 2025
Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019Megan A Clarke, Nicolas Wentzensen, Martin Köbel, et al.
Gynecologic Oncology|November 27, 2019
Reducing emergency department (ED) computed tomography (CT) utilization in women treated for gynecologic cancersStuart A Ostby, Joel G Evans, Haller J Smith, et al.
Gynecologic Oncology|September 8, 2023
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutationMichael D Toboni, Sharon Wu, Alex Farrell, et al.
Gynecologic Oncology|May 25, 2021
Uterine carcinosarcomas: From pathology to practiceMichael D Toboni, Erin K Crane, Jubilee Brown, et al.
Gynecologic Oncology|October 4, 2024
Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinomaTullia Rushton, Harris B Krause, Timothy Samec, et al.
Gynecologic Oncology|July 23, 2025
The use of transrectal ultrasound to improve gynecologic interstitial applicator implantationKatelyn Ragland, Joel Pogue, Eric Simiele, et al.
Gynecologic Oncology|November 18, 2025
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?Michael D Toboni, Elizabeth T Evans, Carly Bess Scalise, et al.
JCO Precision Oncology|September 24, 2025
Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine CancerPeter W Ketch, Carly Bess Scalise, Fernando Recio, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Menopause (New York, N.Y.)|January 13, 2016
Contributing factors for menopausal symptoms after surgical staging for endometrial cancerKoji Matsuo, Marc R Gualtieri, Sigita S Cahoon, et al.
Gynecologic Oncology|January 21, 2025
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcomaMichael D Toboni, Kaitlyn Dinkins, Sharon Wu, et al.
Gynecologic Oncology|August 2, 2025
Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019Megan A Clarke, Nicolas Wentzensen, Martin Köbel, et al.
Gynecologic Oncology|November 27, 2019
Reducing emergency department (ED) computed tomography (CT) utilization in women treated for gynecologic cancersStuart A Ostby, Joel G Evans, Haller J Smith, et al.
Gynecologic Oncology|September 8, 2023
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutationMichael D Toboni, Sharon Wu, Alex Farrell, et al.
Gynecologic Oncology|May 25, 2021
Uterine carcinosarcomas: From pathology to practiceMichael D Toboni, Erin K Crane, Jubilee Brown, et al.
Gynecologic Oncology|October 4, 2024
Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinomaTullia Rushton, Harris B Krause, Timothy Samec, et al.
Gynecologic Oncology|July 23, 2025
The use of transrectal ultrasound to improve gynecologic interstitial applicator implantationKatelyn Ragland, Joel Pogue, Eric Simiele, et al.
Gynecologic Oncology|November 18, 2025
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?Michael D Toboni, Elizabeth T Evans, Carly Bess Scalise, et al.
JCO Precision Oncology|September 24, 2025
Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine CancerPeter W Ketch, Carly Bess Scalise, Fernando Recio, et al.
Pageof 3